Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Drug Design, Development and Therapy Volume 7, 2013 - Issue

Submit an article Journal homepage

Open access

141

Views

CrossRef citations to date

Altmetric

Review

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib

Hannah V Woodcock1 Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK;2 Centre for Respiratory Research, University College London, London, UK

Philip L Molyneaux1 Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK;3 National Heart and Lung Institute, Imperial College London, London, UK

Toby M Maher1 Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK;2 Centre for Respiratory Research, University College London, London, UK;3 National Heart and Lung Institute, Imperial College London, London, UKCorrespondence[email protected]

Pages 503-510 | Published online: 19 Jun 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Quanbin Zha, Ling Zhang, Yuhua Guo, Rui Bao, Feng Shi & Yongkang Shi. (2022) Preparation and Study of Folate Modified Albumin Targeting Microspheres. Journal of Oncology 2022, pages 1-9.
Crossref

Liu Feng, Wang Li, Yu Chao, Qin Huan, Fang Lu, Wang Yi, Wang Jun, Cui Binbin, Liu Na & Zhuang Shougang. (2021) Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy. Kidney Diseases 7:1, pages 34-49.
Crossref

Eva Brunnemer, Julia Wälscher, Svenja Tenenbaum, Julia Hausmanns, Karen Schulze, Marianne Seiter, Claus Peter Heussel, Arne Warth, Felix J.F. Herth & Michael Kreuter. (2018) Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis. Respiration 95:5, pages 301-309.
Crossref

Gerhard Rogler. (2014) New Therapeutic Avenues for Treatment of Fibrosis: Can We Learn from Other Diseases?. Digestive Diseases 32:Suppl. 1, pages 39-49.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references